Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia
NCT ID: NCT06990568
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
100 participants
INTERVENTIONAL
2025-06-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics in the Reduction of Antibiotic Associated Diarrhea
NCT02589964
Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea
NCT01058356
Dose Response Effect of Probiotics for the Prevention of Antibiotic-associated Diarrhea in Chinese Adults
NCT01143623
Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea
NCT01596829
Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
NCT00599430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lacidofil
Take 1 capsule of Lacidofil in the morning and evening after meals, for a total of 2 times a day. The total duration of the dosage is the antibiotic treatment period plus 5 days.
Lacidofil
1 capsule twice daily.
Placebo
Take 1 capsule of placebo in the morning and evening after meals, for a total of 2 times a day. The total duration of the dosage is the antibiotic treatment period plus 5 days.
Placebo
1 capsule twice daily.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lacidofil
1 capsule twice daily.
Placebo
1 capsule twice daily.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients eligible for oral medication administration (able to take oral or enteral feeding)
Exclusion Criteria
* Patients admitted to the intensive care unit (ICU) following endotracheal intubation
* Elderly patients aged 80 years or older
* Pregnant women
* Patients who have diarrhea at the time of admission
* Patients with a history of using probiotics within 3 months prior to admission
* Patients with a history of using laxatives within 1 week prior to admission
* Patients suspected of being in shock (mean arterial pressure \< 65 mmHg) at the time of admission
19 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Health Insurance Service Ilsan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eunki Chung
MD
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NHIMC-2024-CR-070
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2025-01-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.